Showing 1 - 14 results of 14 for search 'Samuel D. Rabkin', query time: 0.05s Refine Results
  1. 1
    Designing herpes viruses as oncolytics

    Designing herpes viruses as oncolytics by Cole Peters, Samuel D Rabkin

    Published 2015-01-01
    Get full text
    Article
  2. 2
    Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells

    Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells by Kimia Kardani, Judit Sanchez Gil, Samuel D. Rabkin

    Published 2023-05-01
    Get full text
    Article
  3. 3
    Triple threat to cancer: rationale for combining oncolytic viruses, MEK inhibitors, and immune checkpoint blockade

    Triple threat to cancer: rationale for combining oncolytic viruses, MEK inhibitors, and immune checkpoint blockade by Praveen K. Bommareddy, Samuel D. Rabkin, Howard L. Kaufman

    Published 2019-04-01
    Get full text
    Article
  4. 4
    Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma

    Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma by Ali Chahlavi, Tomoki Todo, Robert L. Martuza, Samuel D. Rabkin

    Published 1999-06-01
    Get full text
    Article
  5. 5
    In Situ Cancer Vaccination and Immunovirotherapy Using Oncolytic HSV

    In Situ Cancer Vaccination and Immunovirotherapy Using Oncolytic HSV by Nusrat Jahan, Shanawaz M. Ghouse, Robert L. Martuza, Samuel D. Rabkin

    Published 2021-08-01
    Get full text
    Article
  6. 6
    Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma

    Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma by Praveen K. Bommareddy, Andrew Zloza, Samuel D. Rabkin, Howard L. Kaufman

    Published 2019-07-01
    Get full text
    Article
  7. 7
    Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival

    Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival by Howard L Kaufman, Dipongkor Saha, Samuel D Rabkin, Robert L Martuza, Praveen K Bommareddy, Hiroaki Wakimoto

    Published 2024-04-01
    Get full text
    Article
  8. 8
    Ionizing Radiation Does Not Alter the Antitumor Activity of Herpes Simplex Virus Vector G207 in Subcutaneous Tumor Models of Human and Murine Prostate Cancer

    Ionizing Radiation Does Not Alter the Antitumor Activity of Herpes Simplex Virus Vector G207 in Subcutaneous Tumor Models of Human and Murine Prostate Cancer by Timothy J. Jorgensen, Sanford Katz, Ellen K. Wittmack, Susan Varghese, Tomoki Todo, Samuel D. Rabkin, Robert L. Martuza

    Published 2001-01-01
    Get full text
    Article
  9. 9
    Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells

    Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells by Lei Wang, Jianfang Ning, Hiroaki Wakimoto, Shulin Wu, Chin-lee Wu, Melissa R. Humphrey, Samuel D. Rabkin, Robert L. Martuza

    Published 2019-06-01
    Get full text
    Article
  10. 10
    Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models

    Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models by Wei Zhang, Giulia Fulci, Hiroaki Wakimoto, Tooba A. Cheema, Jason S. Buhrman, Deva S. Jeyaretna, Anat O. Stemmer Rachamimov, Samuel D. Rabkin, Robert L. Martuza

    Published 2013-06-01
    Get full text
    Article
  11. 11
    Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma

    Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma by Yoichiro Kawamura, Lingyang Hua, Alessandra Gurtner, Ego Wong, Juri Kiyokawa, Nadia Shah, Joshua Gorham, Hiroko Wakimoto, Samuel D. Rabkin, Robert L. Martuza, Hiroaki Wakimoto

    Published 2022-11-01
    Get full text
    Article
  12. 12
    Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma

    Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma by Ming Li, Guoping Li, Juri Kiyokawa, Zain Tirmizi, Leland G. Richardson, Jianfang Ning, Saumya Das, Robert L. Martuza, Anat Stemmer-Rachamimov, Samuel D. Rabkin, Hiroaki Wakimoto

    Published 2020-12-01
    Get full text
    Article
  13. 13
    An Aberrant Transcription Factor Network Essential for Wnt Signaling and Stem Cell Maintenance in Glioblastoma

    An Aberrant Transcription Factor Network Essential for Wnt Signaling and Stem Cell Maintenance in Glioblastoma by Esther Rheinbay, Mario L. Suvà, Shawn M. Gillespie, Hiroaki Wakimoto, Anoop P. Patel, Mohammad Shahid, Ozgur Oksuz, Samuel D. Rabkin, Robert L. Martuza, Miguel N. Rivera, David N. Louis, Simon Kasif, Andrew S. Chi, Bradley E. Bernstein

    Published 2013-05-01
    Get full text
    Article
  14. 14
    A high-throughput screening and computation platform for identifying synthetic promoters with enhanced cell-state specificity (SPECS)

    A high-throughput screening and computation platform for identifying synthetic promoters with enhanced cell-state specificity (SPECS) by Ming-Ru Wu, Lior Nissim, Doron Stupp, Erez Pery, Adina Binder-Nissim, Karen Weisinger, Casper Enghuus, Sebastian R. Palacios, Melissa Humphrey, Zhizhuo Zhang, Eva Maria Novoa, Manolis Kellis, Ron Weiss, Samuel D. Rabkin, Yuval Tabach, Timothy K. Lu

    Published 2019-06-01
    Get full text
    Article

Search Tools: